Skip to content

Proscillaridin

CARDIOVASCULAR SYSTEM

Also known as: caradrin, cardiovite, desglucotransvaaline, procardin, proscillaridin A, scillacrist

YEAR INTRODUCED approvedATC C01AB01ATC C01AB51

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Proscillaridin is a drug catalogued in DrugCentral. It was first approved by the YEAR INTRODUCED in 1967. DrugCentral lists 2 molecular targets, including ATP1A2 and ATP1A1.

  • Molecular targets: ATP1A2 and ATP1A1 (2 listed in DrugCentral).
  • ATC code: C01AB01 (Scilla glycosides).
  • Molecular formula: C30H42O8; molecular weight 530.66 g/mol.

Mechanism & targets

Molecular targets (2)

TargetGeneActionActivity
Sodium/potassium-transporting ATPase subunit alpha-2ATP1A2unknownIC50 7.06
Sodium/potassium-transporting ATPase subunit alpha-1ATP1A1unknown—

Regulatory approvals (1)

DateAgencyMarketed asApplicantOrphan
1967-01-01YEAR INTRODUCED——

ATC classification

ATC codeTherapeutic hierarchy
C01AB01CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC GLYCOSIDES › Scilla glycosides
C01AB51CARDIOVASCULAR SYSTEM › CARDIAC THERAPY › CARDIAC GLYCOSIDES › Scilla glycosides

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Proscillaridin is on its molecule page.

Molecular formulaC30H42O8
Molecular weight530.66 g/mol
CAS number466-06-8
InChIKeyMYEJFUXQJGHEQK-ALRJYLEOSA-N
PubChem CID5284613
C[C@@H]1O[C@@H](O[C@H]2CC[C@]3(C)[C@H]4CC[C@]5(C)[C@H](CC[C@]5(O)[C@@H]4CCC3=C2)C2=COC(=O)C=C2)[C@H](O)[C@H](O)[C@H]1O

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

How does Proscillaridin work?

Its molecular targets in DrugCentral include ATP1A2 and ATP1A1.

When was Proscillaridin first approved?

Proscillaridin was first approved by the YEAR INTRODUCED in 1967.

What is the chemical formula of Proscillaridin?

Proscillaridin has the molecular formula C30H42O8 and a molecular weight of 530.66 g/mol.

Browse: all drugs starting with P · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval1967-01-01
AgencyYEAR INTRODUCED
Targets2
Indications0
FormulaC30H42O8
DrugCentral ID2313
Interactive profile